Clinics for high risk care: A new concept in the prevention of colorectal cancer;Atención en clínicas de alto riesgo: un nuevo concepto de prevención del cáncer colorrectal

Medicina Clinica

Volumn 131, Issue 10, 2008, Pages 382-386

  Balaguer, Francesc ^a   Ocaña, Teresa ^a   Garrell, Imma ^b   Ferrández, Ángel ^c  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b Médico de Familia Del Consorci d'Atencio Primria de Salut de l'Eixample Casanova   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER PREVENTION; CANCER RISK; COLONOSCOPY; COLORECTAL CANCER; FAMILIAL CANCER; GENETICS; HUMAN; MORTALITY; POLYPOSIS; PROGNOSIS; CLINICAL PROTOCOL; COLORECTAL TUMOR; DECISION TREE; HEALTH CARE FACILITY; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; RISK FACTOR;

CLINICAL PROTOCOLS; COLORECTAL NEOPLASMS; DECISION TREES; HEALTH FACILITIES; HUMANS; MODELS, ORGANIZATIONAL; RISK FACTORS;

EID: 59449109494     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13126143     Document Type: Article

References (28)

1. Castells A. Prevención del cáncer colorrectal. Med Clin (Barc) 117 (2001) 69-75
2. Castells A., Marzo M., Bellas B., Amador F., Lanas A., Mascort J., et al. Guía de práctica clínica en prevención del cáncer colorrectal. Gastroenterol Hepatol 27 (2004) 573-634
3. Jarvinen H.J., Aarnio M., Mustonen H., Aktan-Collan K., Aaltonen L.A., Peltomaki P., et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118 (2000) 829-834
4. Pinol V., Andreu M., Castells A., Paya A., Bessa X., and Rodrigo J. Frequency of hereditary non-polyposis colorectal cancer and other colorectal cancer familial forms in Spain: a multicentre, prospective, nationwide study. Eur J Gastroenterol Hepatol 16 (2004) 39-45
5. Rozen P., and Macrae F. Familial adenomatous polyposis: the practical applications of clinical and molecular screening. Fam Cancer 5 (2006) 227-235
6. Farrington S.M., Tenesa A., Barnetson R., Wiltshire A., Prendergast J., Porteous M., et al. Germline susceptibility to colorectal cancer due to baseexcision repair gene defects. Am J Hum Genet 77 (2005) 1
7. Lynch H.T., Boland C.R., Gong G., Shaw T.G., Lynch P.M., Fodde R., et al. Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet 14 (2006) 390-402
8. Giardiello F.M., and Trimbath J.D. Peutz-Jeghers syndrome and management recommendations. Clin Gastroenterol Hepatol 4 (2006) 408-415
9. Brosens L.A., Van Hattem A., Hylind L.M., Iacobuzio-Donahue C., Romans K.E., Axilbund J., et al. Risk of colorectal cancer in juvenile polyposis. Gut 56 (2007) 965-967
10. Rustgi A.K. Hereditary gastrointestinal polyposis and nonpolyposis syndromes. N Engl J Med 331 (1994) 1694-1702
11. Mandel J.S., Bond J.H., Church T.R., Snover D.C., Bradley G.M., Schuman L.M., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328 (1993) 1365-1371
12. Winawer S., Fletcher R., Rex D., Bond J., Burt R., Ferrucci J., et al. Colorectal cancer screening and surveillance: clinical guidelines and rationaleupdate based on new evidence. Gastroenterology 124 (2003) 544-560
13. Winawer S.J., Zauber A.G., Fletcher R.H., Stillman J.S., O'Brien M.J., Levin B., et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 130 (2006) 1872-1885
14. De la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 4 (2004) 769-780
15. Llor X., Pons E., Xicola R.M., Castells A., Alenda C., Pinol V., et al. Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway. Clin Cancer Res 11 (2005) 7304-7310
16. Balaguer F., Castellví-Bel S., Castells A., Andreu M., Muñoz J., Gisbert J.P., et al. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. Clin Gastroenterol Hepatol 5 (2007) 379-387
17. Galiatsatos P., and Foulkes W.D. Familial adenomatous polyposis. Am J Gastroenterol 101 (2006) 385-398
18. Vasen H.F., Moslein G., Alonso A., Bernstein I., Bertario L., Blanco I., et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 44 (2007) 353-362
19. Terdiman J.P., Levin T.R., Allen B.A., Gum Jr. J.R., Fishbach A., Conrad P.G., et al. Hereditary nonpolyposis colorectal cancer in young colorectal cancer patients: high-risk clinic versus population-based registry. Gastroenterology 122 (2002) 940-947
20. Umar A., Boland C.R., Terdiman J.P., Syngal S., De la Chapelle A., Ruschoff J., et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96 (2004) 261-268
21. Pinol V., Castells A., Andreu M., Castellví-Bel S., Alenda C., Llor X., et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 293 (2005) 1986-1994
22. Vasen H.F., Watson P., Mecklin J.P., and Lynch H.T. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116 (1999) 1453-1456
23. Xicola R.M., Llor X., Pons E., Castells A., Alenda C., Pinol V., et al. Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors. J Natl Cancer Inst 99 (2007) 244-252
24. Balmana J., Stockwell D.H., Steyerberg E.W., Stoffel E.M., Deffenbaugh A.M., Reid J.E., et al. Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA 296 (2006) 1469-1478
25. Balaguer F., Balmaña J., Castellví-Bel S., Steyerberg E., Andreu M., Llor X., et al. Validation and extension of the PREMM1,2 model in a populationbased cohort of colorectal cancer patients. Gastroenterology 134 (2008) 39-46
26. Barnetson R.A., Tenesa A., Farrington S.M., Nicholl I.D., Cetnarskyj R., Porteous M.E., et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 354 (2006) 2751-2763
27. Zauber A.G., and Winawer S.J. High-quality colonoscopies must be an integral part of screening and surveillance programs. Gastroenterology 130 (2006) 620-621
28. Gaff C.L., Rogers M.T., and Frayling I.M. Genetic counselling and consent for tumour testing in HNPCC. Clin Genet 71 (2007) 400-405